UTime Limited (NASDAQ: WTO) (“UTime” or the “Company”) is pleased to announce its plans to participate in a number of internationally recognized medical trade shows and professional conferences. The upcoming events provide UTime with a valuable opportunity to showcase its latest achievements in medical devices and medical solutions and to enhance its communications and partnerships within the global medical industry.
At the upcoming MEDICA in Düsseldorf, one of the world’s most influential trade fairs for medical technology and devices, UTime plans to showcase its latest innovations in medical monitoring devices and intelligent diagnostic tools. The company’s exhibition stand aims to present its pioneering work across the entire value chain of medical technology products.
In addition to MEDICA, UTime plans to participate in the Cardiology Society Conference, the Sleep Conference and the Hypertension Conference in the USA. These conferences bring together leading medical experts and scientists under one roof and provide UTime not only a platform to showcase its technological advances to the industry, but also an excellent opportunity to learn from colleagues from around the world and gain important insights.
These planned participations underscore UTime’s ongoing commitment to impacting the global medical and healthcare landscape and demonstrate the company’s mission to improve human health through technological innovation.
UTime also intends to explore possible collaboration projects with various international health organizations and research institutes, particularly in the areas of telemedicine and application of artificial intelligence in healthcare. Through such international collaborations, the company aims to accelerate the global introduction of its products, which ultimately benefits patients worldwide.
Information about UTime Limited
UTime is committed to improving health and well-being through innovative medical wearable technologies. By leveraging cutting-edge research and strategic partnerships, UTime aims to provide effective solutions for disease prevention and health management on a global scale. For more information, please visit the company’s website at http://www.utimeworld.com/.
Forward-Looking Statements
Statements in this press release regarding future expectations, plans and prospects and any other statements on matters that are not historical facts may constitute “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the U.S. Private Securities Exchange Act Litigation Reform Act of 1995 The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “ “predict”, “project”, “should”, “target”, “will”, “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may vary due to various important factors discussed in the “Risk Factors” section of the Company’s Annual Report on Form 20-F filed with the U.S. Securities and Exchange Commission on July 30, 2024, could differ materially from the results contained in such forward-looking statements. Any forward-looking statements contained in this press release speak only as of the date hereof and the Company expressly disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.
For further information please contact:
Eaky Tan
View original content:https://www.prnewswire.com/news-releases/utime-limited-nimmt-an-internationalen-medizinmessen-und-medizinischen-konferenzen-teil-302229630.html